Vioxx

A Free Service Provided By www.FactsOfLaw.com
Home

Sponsored Links

 


Click Above

Legal Topics

Arbitration and Mediation
Bankruptcy
Bextra
Car Accidents
Celebrex
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
Death
Divorce
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Fen-Phen
Immigration Law

Lawsuits
Lemon Law
Marriage
Medical Malpractice
Megan's Law
Meridia
Mesothelioma & Asbestos

Mold
Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Vioxx
Wills
Workers' Compensation
Work Related Injury

Legal Kits

 

Facts - Books - News    U.S. Facts Of Law:

Vioxx - Rofecoxib

Rofecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea. Formerly marketed by Merck & Co. under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke.

Rofecoxib was one of the most widely used drugs ever to be withdrawn from the market. Worldwide, over two million people were prescribed Vioxx at the time. In the year before withdrawal, Merck had a sales revenue of US$2.5 billion from Vioxx.

Rofecoxib was available on prescription as tablets and as an oral suspension.

 

Refecoxib Best Sellers from Amazon.com

High-dose rofecoxib linked to increased MI risk: observational study data 'ca...
by Nancy Walsh
Amazon Price: $5.95

Rofecoxib approved as rheumatoid arthritis Tx.(News): An article from: Pediat...
by Kerri Wachter
Amazon Price: $5.95

FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly unanimous ...
by Elizabeth Mechcatie
Amazon Price: $5.95

Fewer GI Events With Supertherapeutic Doses of Rofecoxib.: An article from: F...
by Betsy Bates
Amazon Price: $5.95

Second COX-2 Inhibitor Gets Nod From FDA Panel.: An article from: Family Prac...
by Elizabeth Mechcatie
Amazon Price: $5.95


Newsfeed display by CaRP

Refecoxib News

Vioxx Safety Data Manipulated The Hindu
A Mercks internal communication talks of the drug being associated with an increased risk of causing deaths

IMPORTANT NOTICE: The information provided by FactsOfLaw.com does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. FactsOfLaw.com has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney. Source: wikipedia.org

Copyright © 2008 All Rights Reserved - FactsOfLaw.com